年間 6 号発行
ISSN 印刷: 1045-4403
ISSN オンライン: 2162-6502
Indexed in
Regulatory Mechanisms in Vascular Calcification
要約
Vascular calcification is increasingly recognized as a significant contributor to cardiovascular morbidity and mortality as well as a biologically regulated process potentially subject to prevention and reversal.
Both coronary and aortic calcification are common and influence plaque rupture, angioplasty and surgical complications, and compensatory enlargement. Aortic calcification increases aortic rigidity and contributes to cadiac ischemia, left ventricular hypertrophy, heart failure, and stroke. Calcification is also common in aortic valve leaflets further compounding adverse hemodynamic effects.
Vascular calcification has often been attributed to "passive" crystallization. However, functional similarities between atherosclerotic lesions and bone contradict this view and indicate that it is no more "passive" than in embryonic bone formation or bone repair. Similarities include presence of all the major components of bone osteoid, bone regulatory factors, and subpopulations of artery wall cells that retain osteoblastic lineage potential.
Several animal models for vascular calcification are available. Spontaneous vascular calcification occurs in null mice for matrix GLA protein (MGP), a small matrix protein of unknown function, and osteoprotegerin (OPG), known to modulate osteoclast differentiation. Vascular calcification may also be induced by feeding vitamin D and calcium or warfarin to normal animals, or by fat-feeding mice null for apoE or the LDL-receptor.
Overall, regulation of vascular calcification is a growing field with surprising mechanisms and connections to other fields of biology.
-
Villines Todd C., Hatzigeorgiou Christos, Feuerstein Irwin M., O??Malley Patrick G., Taylor Allen J., Vitamin K1 intake and coronary calcification, Coronary Artery Disease, 16, 3, 2005. Crossref
-
Schäfer Cora, Heiss Alexander, Schwarz Anke, Westenfeld Ralf, Ketteler Markus, Floege Jürgen, Müller-Esterl Werner, Schinke Thorsten, Jahnen-Dechent Willi, The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification, Journal of Clinical Investigation, 112, 3, 2003. Crossref
-
Zannettino A.C.W., Holding C.A., Diamond P., Atkins G.J., Kostakis P., Farrugia A., Gamble J., To L.B., Findlay D.M., Haynes D.R., Osteoprotegerin (OPG) is localized to the Weibel-Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor, Journal of Cellular Physiology, 204, 2, 2005. Crossref
-
Roos Marcel, Lutz Jens, Salmhofer Hermann, Luppa Peter, Knauß Amelie, Braun Siegmund, Martinof Stefan, Schömig Albert, Heemann Uwe, Kastrati Adnan, Hausleiter Jörg, Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function, Clinical Endocrinology, 68, 4, 2008. Crossref
-
Chen Neal X., O'Neill Kalisha D., Duan Danxia, Moe Sharon M., Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells, Kidney International, 62, 5, 2002. Crossref
-
Choi Woong Hwan, Epidemiology and Biological Correlation Between Osteoporosis and Atherosclerosis, Journal of Korean Society of Endocrinology, 20, 6, 2005. Crossref
-
Gajda M., Banaś K., Banaś A., Jawień J., Mateuszuk Ł., Chłopicki S., Kwiatek W. M., Cichocki T., Falkenberg G., Distribution of selected elements in atherosclerotic plaques of apoE/LDLR-double knockout mice assessed by synchrotron radiation-induced micro-XRF spectrometry, X-Ray Spectrometry, 37, 5, 2008. Crossref
-
Dunmore-Buyze P J, Moreau M, Fenster A, Holdsworth D W, In vitro investigation of calcium distribution and tissue thickness in the human thoracic aorta, Physiological Measurement, 23, 3, 2002. Crossref
-
Goodman William G, London Gerard, Amann Kerstin, Block Geoffrey A, Giachelli Cecilia, Hruska Keith A, Ketteler Markus, Levin Adeera, Massy Ziad, McCarron David A, Raggi Paolo, Shanahan Catherine Mary, Yorioka Noriaki, Vascular calcification in chronic kidney disease, American Journal of Kidney Diseases, 43, 3, 2004. Crossref
-
Iribarren Carlos, Go Alan S., Tolstykh Irina, Sidney Stephen, Johnston S. Claiborne, Spring David B., Breast Vascular Calcification and Risk of Coronary Heart Disease, Stroke, and Heart Failure, Journal of Women's Health, 13, 4, 2004. Crossref
-
Delibasi Tuncay, Emral Rifat, Erdogan Murat F., Kamel Nuri, Effects of alendronate sodium therapy on carotid intima media thickness in postmenopausal women with osteoporosis, Advances in Therapy, 24, 2, 2007. Crossref
-
Wilmer William A, Magro Cynthia M, Calciphylaxis: Emerging Concepts in Prevention, Diagnosis, and Treatment, Seminars in Dialysis, 15, 3, 2002. Crossref
-
Moe Sharon M., Duan Danxia, Doehle Brian P., O'Neill Kalisha D., Chen Neal X., Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels, Kidney International, 63, 3, 2003. Crossref
-
Rajaram Venkataraman, Pandhya Sanjay, Patel Samir, Meyer Peter M, Goldin Marshall, Feinstein Matt J.M, Neems Rachel, Liebson Philip R, Fiedler Benjamin M, Macioch James E, Feinstein Steven B, Role of surrogate markers in assessing patients with diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapy, The American Journal of Cardiology, 93, 11, 2004. Crossref
-
Doherty Terence M., Fitzpatrick Lorraine A., Shaheen Aisha, Rajavashisth Tripathi B., Detrano Robert C., Genetic Determinants of Arterial Calcification Associated With Atherosclerosis, Mayo Clinic Proceedings, 79, 2, 2004. Crossref
-
El-Saed Aiman, Sekikawa Akira, Edmundowicz Daniel, Evans Rhobert W., Sutton-Tyrrell Kim, Kadowaki Takashi, Choo Jina, Takamiya Tomoko, Kuller Lewis H., Coronary calcification is more predictive of carotid intimal medial thickness in black compared to white middle aged men, Atherosclerosis, 196, 2, 2008. Crossref
-
TOWLER DWIGHT A., CLEMENS THOMAS L., Vitamin D and Cardiovascular Medicine, in Vitamin D, 2005. Crossref
-
Kohn Michael H., Price Roger E., Pelz Hans-Joachim, A cardiovascular phenotype in warfarin-resistantVkorc1mutant rats☆, Artery Research, 2, 4, 2008. Crossref
-
Vassalle Cristina, Maffei Silvia, Iervasi Giorgio, Bone Remodeling Biomarkers: New Actors on the Old Cardiovascular Stage, in Biomarker Validation, 2015. Crossref
-
Simpson Chartrisa LaShan, Lindley Suzanne, Eisenberg Carol, Basalyga Dina M., Starcher Barry C., Simionescu Dan T., Vyavahare Narendra R., Toward cell therapy for vascular calcification: osteoclast-mediated demineralization of calcified elastin, Cardiovascular Pathology, 16, 1, 2007. Crossref
-
Hill Jennifer A., Goldin Jonathan G., Gjertson David, Emerick Aletha M., Greaser Lloyd D., Yoon Hyo-Chun, Khorrami Shauna, Aziz Donya, Adams John S., Progression of Coronary Artery Calcification in Patients Taking Alendronate for Osteoporosis, Academic Radiology, 9, 10, 2002. Crossref
-
Gomez Felicia, Wang Lihua, Abel Haley, Zhang Qunyuan, Province Michael A, Borecki Ingrid B, Admixture mapping of coronary artery calcification in African Americans from the NHLBI family heart study, BMC Genetics, 16, 1, 2015. Crossref
-
LUIS MILLÁN JOSÉ, Alkaline Phosphatases, in Dynamics of Bone and Cartilage Metabolism, 2006. Crossref
-
Kajbaf Sahar, Veinot John P., Ha Andrew, Zimmerman Deborah, Comparison of Surgically Removed Cardiac Valves of Patients With ESRD With Those of the General Population, American Journal of Kidney Diseases, 46, 1, 2005. Crossref
-
Veinot John P., Pathology of inflammatory native valvular heart disease, Cardiovascular Pathology, 15, 5, 2006. Crossref
-
Lee Chi H, Physiological variables involved in heart valve substitute calcification, Expert Opinion on Biological Therapy, 9, 8, 2009. Crossref
-
Simionescu Agneta, Simionescu Dan T., Vyavahare Narendra R., Osteogenic Responses in Fibroblasts Activated by Elastin Degradation Products and Transforming Growth Factor-β1, The American Journal of Pathology, 171, 1, 2007. Crossref
-
Isenburg Jason C., Simionescu Dan T., Vyavahare Naren R., Elastin stabilization in cardiovascular implants: improved resistance to enzymatic degradation by treatment with tannic acid, Biomaterials, 25, 16, 2004. Crossref
-
Ylitalo Ritva, Bisphosphonates and atherosclerosis, General Pharmacology: The Vascular System, 35, 6, 2000. Crossref
-
Boström Kristina I., Yao Jiayi, Guihard Pierre J., Blazquez-Medela Ana M., Yao Yucheng, Endothelial-mesenchymal transition in atherosclerotic lesion calcification, Atherosclerosis, 253, 2016. Crossref
-
Kanazawa Ippei, Yamaguchi Toru, Shimizu Tadashi, Hayashi Kumi, Takase Hirofumi, Sugimoto Toshitsugu, Effects of Treatment With Risedronate and Alfacalcidol on Progression of Atherosclerosis in Postmenopausal Women With Type 2 Diabetes Mellitus Accompanied With Osteoporosis, The American Journal of the Medical Sciences, 339, 6, 2010. Crossref
-
Ix Joachim H., Chertow Glenn M., Shlipak Michael G., Brandenburg Vincent M., Ketteler Markus, Whooley Mary A., Fetuin-A and kidney function in persons with coronary artery disease—data from the heart and soul study, Nephrology Dialysis Transplantation, 21, 8, 2006. Crossref
-
Yamanouchi Dai, Takei Yuichiro, Komori Kimihiro, Balanced Mineralization in the Arterial System, Circulation Journal, 76, 12, 2012. Crossref
-
Santos Leyna L., Cavalcanti Taciana B., Bandeira Francisco A., Vascular Effects of Bisphosphonates–-A Systematic Review, Clinical Medicine Insights: Endocrinology and Diabetes, 5, 2012. Crossref
-
Doherty Terence M., Uzui Hiroyasu, Fitzpatrick Lorraine A., Tripathi Pinky V., Dunstan Colin R., Asotra Kamlesh, Rajavashisth Tripathi B., Rationale for the role of osteoclast‐like cells in arterial calcification, The FASEB Journal, 16, 6, 2002. Crossref
-
Stouffer George A., Atherosclerosis, in Principles of Molecular Cardiology, 2005. Crossref
-
Lim E. T. S., Anand D. V., Lahiri A., Noninvasive Assessment of Asymptomatic Individuals at Risk of Coronary Heart Disease. Part a, in Noninvasive Imaging of Myocardial Ischemia, 2006. Crossref
-
Schurgers Leon J., Spronk Henri M. H., Soute Berry A. M., Schiffers Paul M., DeMey Jo G. R., Vermeer Cees, Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats, Blood, 109, 7, 2007. Crossref
-
Calcifying Matrices: Pathological Calcifications, in Biological Calcification, 2007. Crossref
-
The Nature and Composition of the Inorganic Phase, in Biological Calcification, 2007. Crossref
-
Chen Yabing, Zhao Xinyang, Wu Hui, Transcriptional Programming in Arteriosclerotic Disease, Arteriosclerosis, Thrombosis, and Vascular Biology, 2020. Crossref
-
Hirose Ken-ichi, Tomiyama Hirofumi, Okazaki Ryo, Arai Tomio, Koji Yutaka, Zaydun Gulnisa, Hori Saburo, Yamashina Akira, Increased Pulse Wave Velocity Associated with Reduced Calcaneal Quantitative Osteo-sono Index: Possible Relationship Between Atherosclerosis and Osteopenia, The Journal of Clinical Endocrinology & Metabolism, 88, 6, 2003. Crossref
-
Chen Yabing, Zhao Xinyang, Wu Hui, Arterial Stiffness, Arteriosclerosis, Thrombosis, and Vascular Biology, 40, 5, 2020. Crossref
-
Shao Jian-Su, Cheng Su-Li, Charlton-Kachigian Nichole, Loewy Arleen P., Towler Dwight A., Teriparatide (Human Parathyroid Hormone (1–34)) Inhibits Osteogenic Vascular Calcification in Diabetic Low Density Lipoprotein Receptor-deficient Mice, Journal of Biological Chemistry, 278, 50, 2003. Crossref
-
Du Heng, Yang Wenjie, Chen Xiangyan, Histology-Verified Intracranial Artery Calcification and Its Clinical Relevance With Cerebrovascular Disease, Frontiers in Neurology, 12, 2022. Crossref
-
Derwall Matthias, Malhotra Rajeev, Lai Carol S., Beppu Yuko, Aikawa Elena, Seehra Jasbir S., Zapol Warren M., Bloch Kenneth D., Yu Paul B., Inhibition of Bone Morphogenetic Protein Signaling Reduces Vascular Calcification and Atherosclerosis, Arteriosclerosis, Thrombosis, and Vascular Biology, 32, 3, 2012. Crossref
-
Dhore Cherida R., Cleutjens Jack P.M., Lutgens Esther, Cleutjens Kitty B.J.M., Geusens Piet P.M., Kitslaar Peter J.E.H.M., Tordoir Jan H.M., Spronk Henri M.H., Vermeer Cees, Daemen Mat J.A.P., Differential Expression of Bone Matrix Regulatory Proteins in Human Atherosclerotic Plaques, Arteriosclerosis, Thrombosis, and Vascular Biology, 21, 12, 2001. Crossref
-
Qunibi Wajeh Y., Dyslipidemia and progression of cardiovascular calcification (CVC) in patients with end-stage renal disease (ESRD), Kidney International, 67, 2005. Crossref
-
Cheng Su-Li, Shao Jian-Su, Charlton-Kachigian Nichole, Loewy Arleen P., Towler Dwight A., Msx2 Promotes Osteogenesis and Suppresses Adipogenic Differentiation of Multipotent Mesenchymal Progenitors, Journal of Biological Chemistry, 278, 46, 2003. Crossref
-
Lindner Volkhard, Wang Qiaozeng, Conley Barbara A., Friesel Robert E., Vary Calvin P.H., Vascular Injury Induces Expression of Periostin, Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 1, 2005. Crossref
-
Ramachandran Bindu, Stabley John N., Cheng Su-Li, Behrmann Abraham S., Gay Austin, Li Li, Mead Megan, Kozlitina Julia, Lemoff Andrew, Mirzaei Hamid, Chen Zhijian, Towler Dwight A., A GTPase-activating protein–binding protein (G3BP1)/antiviral protein relay conveys arteriosclerotic Wnt signals in aortic smooth muscle cells, Journal of Biological Chemistry, 293, 21, 2018. Crossref